Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.

Published:1986 Issue:1 Volume:39 Page:170-173
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J. Antibiot.

Author:

UMEZAWA HAMAO,IMOTO MASAYA,SAWA TSUTOMU,ISSHIKI KUNIO,MATSUDA NAOKO,UCHIDA TAKESHI,IINUMA HIRONOBU,HAMADA MASA,TAKEUCHI TOMIO

Publisher

Japan Antibiotics Research Association

Subject

Drug Discovery,Pharmacology

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance;Chemical Science;2024

2. Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID;Archives of Microbiology;2023-05-17

3. Coordinated NADPH oxidase/hydrogen peroxide functions regulate cutaneous sensory axon de- and regeneration;Proceedings of the National Academy of Sciences;2022-07-19

4. Approach toward molecular targeted therapy for cancer using microbial products;J ANTIBIOT;2021

5. Approach toward molecular targeted therapy for cancer using microbial products;The Journal of Antibiotics;2021-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP